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Anterior and posterior default mode
network
a b s t r a c t
Previous voxel-based morphometry (VBM) studies revealed that hippocampal volume loss in patients
with late life depression (LLD) is associated with cognitive impairment and a higher risk for dementia.
However, LLD patients can experience hippocampal atrophy without cognitive impairment. Thus, while
LLD and AD can show comparable hippocampal atrophy, they may encompass different neuropatholo-
gical changes. Using VBM, we therefore investigated differences in regional gray matter changes in 17
late-onset LLD patients and 21 AD patients (without a history of LLD) who exhibited comparably severe
atrophy of the entorhinal cortex and the parahippocampal gyrus on MRI scans for voxel-based speciﬁc
regional analysis system for AD (VSRAD). Relative to the VSRAD database for healthy individuals,
signiﬁcant atrophy was observed in mesial temporal lobe structures and the anterior cingulate cortex in
both groups. Atrophy of the posterior cingulate cortex and precuneus was observed only in the AD
group. Comparisons of gray matter volume by multivariate analysis of variance revealed signiﬁcantly
reduced volume of the right middle and inferior temporal gyrus, uncus, posterior cingulate cortex, and
precuneus in the AD group only, suggesting impairment of different networks in AD and LLD. Indeed,
structural changes in the posterior part of the default-mode network are believed to be associated with
cognitive impairments speciﬁc to AD.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Late life depression (LLD) is a common psychiatric disorder that
is deﬁned as a major depressive episode occurring in older adults
(usually after 60 or 65 years of age). LLD is a heterogeneous mood
disorder frequently associated with cognitive impairment. (Byers
et al., 2010; Weisenbach et al., 2012). Thus, it is important to
distinguish between dementia and LLD clinically, but the distinc-
tion has proved to be difﬁcult.
Indeed, several reports have suggested that LLD might be a risk
factor in Alzheimer's disease (AD) (Jorm, 2001; Diniz et al., 2013).
Moreover, some forms of LLD are considered to constitute pro-
dromal symptoms of dementia (Schweitzer et al., 2002). Consis-
tent with this, Ownby et al. (2006) reported that a history of
depression is associated with an increased risk for developing AD.
Magnetic resonance imaging (MRI) studies have found that a
history of depression and total duration of depression is correlated
with hippocampal volume loss (Sheline et al., 1996; Bell-McGinty et al.,
2002). A relationship between reduced hippocampal volume and LLD
speciﬁcally has also been reported, and this is also associated with
poor performance on the Mini-Mental State Examination (MMSE), a
test used to assess cognitive impairment (Sawyer et al., 2012). There
appears to be a general consensus that in a subset of LLD patients,
there is a reduction in the volume of brain regions that are affected
early in AD, including frontal and medial temporal lobe (MTL)
structures (Sexton et al., 2012). A number of potential mechanisms
underlying hippocampal atrophy in dementia have been proposed.
One possible explanation is that glucocorticoid-induced neurotoxicity
induces hippocampal neural loss, leading to dementia (Lupien et al.,
1998). Alternatively, cortisol-induced atrophy of the hippocampus may
increase amyloid plaque deposition, which may be a risk factor, or
prodromal indicator, of dementia (Byers and Yaffe, 2011). While there
are several lines of evidence that link hippocampal atrophy to AD, the
cause of hippocampal atrophy in late-onset LLD and its relationship to
AD has not yet been determined.
The voxel-based speciﬁc regional analysis system for AD (VSRAD),
which targets the MTL, was developed as a sensitive diagnostic tool to
detect early stages of AD (Hirata et al., 2005). VSRAD enabled the
evaluation of the degree of entorhinal cortex and parahippocampal
volume loss by comparing a given subject's gray matter (GM) volume
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with that of the original healthy individual database template. The
Z-score obtained from the VSRAD became an indicator of the degree of
GM atrophy of the hippocampal region in the diagnosis of early AD.
A Z-score 42 was deﬁned as signiﬁcant atrophy of the hippocampal
region according to previous studies (Matsuda et al., 2012; Matsuda,
2013). However, a Z-score 42 is not necessarily synonymous with a
diagnosis of early AD, and, conversely, a diagnosis of LLD, which does
not show the same cognitive deﬁcits as AD, may be associated with
this Z-score. In addition to being used in the early diagnosis of AD, the
VSRAD approach has been used to estimate regional GM atrophy in
depression.
Thus, in this study, we used VSRAD to compare regional GM
volume abnormalities in AD with those observed in late-onset LLD.
It is thought that the degree of atrophy of MTL structures is generally
related to the grade of memory impairment. However, because the
cause of the hippocampal atrophy in LLD was not clear in the
present cases, where the grade of degeneration of MTL structures
coincided with that found in AD, we predicted that there would be
neuropathologically different features between LLD and AD, even
when the degree of hippocampal atrophy between the two diseases
was comparable. Thus, based on previous MRI studies in AD and LLD
patients, we hypothesized that AD patients may show greater GM
volume abnormalities in temporal and parietal regions, in particular
the posterior cingulate gyrus and precuneus, while LLD patients may
show greater GM volume abnormalities in frontal and limbic
regions, including the anterior cingulate cortex.
2. Methods
2.1. Subjects
This study was conducted with the approval of the ethics committee of Nippon
Medical School Chiba Hokuso Hospital. The purpose of the study was explained to all
subjects, both verbally and in written form, and their informed consent was
obtained. Participants were recruited for this study from a group of 188 outpatients
(54–92 years of age) who visited Nippon Medical School Chiba Hokuso Hospital
complaining of memory loss, and who subsequently underwent MRI scans for
VSRAD analysis between January 2011 and December 2012. The 38 patients (15
males/23 females) who were included in this study obtained a VSRAD Z-score of two
or more. The subjects were divided into two groups. Of the 38 patients, 21 met
(1) the DSM-IV-TR criteria for AD, and (2) the consensus criteria of the National
Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's
Disease and Related Disorders Association (NINCDS–ADRDA) for probable AD. The
remaining 17 patients met DSM-IV-TR criteria for major depressive disorder (MDD)
as well as satisfying the criteria in the International Classiﬁcation of Diseases, 10th
version (ICD-10). All MDD patients had experienced an onset of major depressive
episodes at 60 years of age or older, consistent with a diagnosis of LLD. AD patients
with a history of depression, and LLD patients with mild cognitive impairments
(MCI; deﬁned by Petersen et al. (2001)) or cognitive impairment beyond this, seen
clinically as 0.5 or more on the Clinical Dementia Rating (CDR) Scale and an MMSE of
23 or less, were excluded from the study. Participants were also excluded if they met
criteria for another major psychiatric illness (schizophrenia, schizoaffective disorder,
bipolar disorder). Patients with LDD who had received electroconvulsive therapy
were excluded. Patients with a neurological illness other than dementia that could
lead to cognitive impairment or that was associated with structural brain changes,
and those with a history of brain injury, were also excluded from the study.
2.2. Initial assessment
General cognitive function was assessed with the Mini Mental State Examina-
tion (MMSE) (Folstein et al., 1975) and the Alzheimer's Disease Assessment Scale
(ADAS) word recall subtest (Mohs et al., 1983; Honma et al., 1992). Participants
were asked for their history of depressive episodes. A history of drug therapy and
age of onset were determined from a questionnaire and from family interviews.
Symptoms and severity of depression were assessed using the 17-item Hamilton
Depression Rating Scale (HAM-D) (Hamilton, 1960) at the initial interview.
2.3. MRI measurement
All subjects underwent T1 and T2 two-dimensional diffusion weighted-
echoplanar imaging in a 1.5 T MRI system (Signa Horizon HD, GE Healthcare
Technologies, Milwaukee, WI, USA). For VSRAD analysis, three-dimensional sagittal
sections of the brains were acquired with the following parameters: inversion time
400 ms, repetition time 11.8 ms, echo time 5.1 ms, ﬂip angle 251, ﬁeld of view
240 mm, acquisition matrix, 256256, and slice thickness 1.4 mm.
2.4. Voxel-based morphometry
VSRAD Advance (Eisai Co, Ltd, Tokyo, Japan) segmented the MRI scans into gray
matter (GM), white matter (WM), and cerebrospinal ﬂuid (CSF) images by a uniﬁed
tissue-segmentation procedure after correcting for image-intensity non-uniformity.
These linearly transformed and segmented images were nonlinearly transformed
by DARTEL procedures and then modulated to the customized template for DARTEL
followed by smoothing using an 8-mm full width at half-maximum kernel. The
segmented images were compared with the mean and standard deviation of the
GM or WM images of the 80 healthy controls that are included in the VSRAD
software using voxel by-voxel Z-score analysis (Z-score¼ ([control-mean][indi-
vidual value])/(control SD)). These Z-score maps were superimposed on tomo-
graphic sections of each individual brain. VSRAD registered the target volume of
interest (VOI) in the medial temporal structures including the entire region of the
entorhinal cortex, hippocampus, and amygdala. This was accomplished by compar-
ing the VOI in patients with early AD with that of healthy controls. First, statistical
analysis for the jackknife method comparing the image of the individual patient
and the mean image of the healthy control database is used in VSRAD. Therefore,
the mean image of each group was created using SPM8 (Statistical Parametric
Mapping version 8, Wellcome Department of Imaging Neuroscience, London, UK).
A Z-score map of GM loss is created by mean image comparison for each group and
mean image of a healthy control database using VSRAD. Next, using global
normalized GM data processed by VSRAD based on SPM8 plus DARTEL, the GM
volume difference between the LLD group and the AD group was investigated by
multivariate analysis of variance (MANCOVA), with age, education, duration of
illness, and Z-score as covariates. A whole-brain between-group comparison
(LLD4AD and AD4LLD) search for signiﬁcant clusters with an extent threshold
of more than 15 voxels was performed under an uncorrected threshold of po0.001.
In addition, regional GM changes were evaluated using the Wake Forest University
(WFU) PickAtlas tool (Maldjian, ohttp://www.nitrc.org/projects/wfu_pickatlas4)
(Tzourio-Mazoyer et al., 2002). The WFU PickAtlas provides a method for generat-
ing region-of-interest (ROI) masks based on the Talairach Daemon database. A
statistical threshold of po0.001 was used.
2.5. Statistical analysis
Basic group comparisons such as a one-way analysis of variance (ANOVA) and a
Chi-square test or a Fisher's exact test were used. Analyses were performed using
JMP8 and SAS version 9 (SAS Institute, Inc., Cary, NC), and a p-value of less than 0.05
was considered statistically signiﬁcant.
3. Results
3.1. Background characteristics
Table 1 presents the demographic, clinical, and neuropsycho-
logical characteristics of participants. There were no signiﬁcant
differences in age, sex, education, or duration of disease or VSRAD
Z-score between the LLD and the AD groups. However, AD subjects
scored signiﬁcantly lower in the MMSE and the ADAS word recall
Table 1
Background characteristics of LLD and AD groups.
Group LLD (n¼17) AD (n¼21) p-value
Sex F/M 10/7 13/8 0.85
Age 77.5 (8.7) 79.4 (7.5) 0.47
Education 11.5 (1.3) 10.7 (2.1) 0.18
Duration of disease 2.7 (0.8) 3.1 (1.3) 0.32
MMSE 25.4 (1.5) 13.8 (5.1) 0.001
ADAS word recall test 1.3 (0.9) 4.4 (1.9) 0.001
HAM-D 13.6 (2.5) 6.5 (1.9) 0.001
Z-score (VSRAD advance) 3.0 (0.6) 3.2 (0.7) 0.26
Medication
Antidepressant (n¼13) ACheI (n¼8)
Other (n¼5) Other (n¼6)
Values are shown as means (S.D.).
ACheI: acetylcholinesterase inhibitor.
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test relative to patients with LLD, indicating greater cognitive
impairment in the AD group. LLD subjects (mean score 13.672.5,
range 6–17) scored higher on the HAM-D scale relative to patients
with AD (mean score 6.571.9, range 4–12), conﬁrming a greater
severity of depression in LLD patients. Of the 17 LLD patients, 13
were being treated with antidepressants. Eight patients with AD
were taking acetylcholinesterase inhibitors (ACheI); the remaining
13 patients were not receiving any drug therapy for AD.
3.2. Z-score map of GM volume reductions in LLD and AD
The Z-score map indicates GM volume reduction obtained and
compares the mean image of the healthy control group and the
mean image of each clinical group using the VSRAD program (see
Fig. 1. Signiﬁcant atrophy was observed in mesial temporal lobe
structures, including the entorhinal cortex, hippocampus and
amygdala, the orbitofrontal cortex, the anterior cingulate cortex,
and the pons, in both groups. Signiﬁcant atrophy of the posterior
cingulate cortex (PCC), precuneus and right cerebellum was found
only in the AD group (Fig. 1).
3.3. Comparison of regional GM volume between LLD and AD
patients
We compared the GM volumes in the LLD group and the AD
group. An automated atlas-based VOI analysis method revealed a
signiﬁcant reduction in GM volume in the right and left precuneus,
the right middle and inferior temporal gyrus, the uncus, and the
PCC regions in the AD group compared with the LLD group. On the
other hand, no speciﬁc GM volume was found to be signiﬁcantly
decreased in the LLD group relative to the AD group (Table 2).
4. Discussion
Although several voxel-based morphometric studies have
reported a correlation between AD and LLD (Modrego and
Ferrández, 2004; Robert et al., 2006; Gabryelewicz et al., 2007;
Palmer et al., 2007; Houde et al., 2008), this study is the ﬁrst to
compare differences in brain structure volume in AD and late-
onset LLD with comparable hippocampal atrophy. Here, we show
using VSRAD that a number of regions were atrophied in both AD
Fig. 1. Z-score map of gray matter volume reductions in LLD and AD groups using VSRAD. (LLD, n¼17; AD, n¼21). VSRAD provides a color-scaled Z-score map ranging from
2.0 to 6.0 with overlaid orthogonal sections of an anatomically standardized brain template. (Purple circles indicate the VSRAD voxel of interest.).
Table 2
Summary of brain regions with signiﬁcantly reduced gray matter volumes: a
comparison between LLD and AD.
Region BA Talairach coordinates Voxel size Z-score
x y z
ADoLLD
R-middle temporal gyrus 21 53 45 10 44 4.41
R-inferior temporal gyrus 20 63 17 21 101 4.44
R-uncus 34 9 31 124 3.63
R-precuneus/PCC 23, 31 8 47 23 147 3.68
L-precuneus 7 11 56 36 44 3.51
BA: Brodmann Area; PCC: Posterior cingulate cortex.
Signiﬁcance level of po0.001 (uncorrected).
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and LLD, including the parahippocampal gyrus, the amygdala and
the anterior cingulate cortex, and that this reduction is dramatic
compared with the healthy individual database included in the
VSRAD software. However, unlike the AD group, the LLD group
showed no evidence of atrophy in the precuneus and the PCC. Our
ﬁndings suggest that changes in more posterior parts of the brain
may be more likely to be observed in AD. These results indicate
that while there are common sites of GM volume loss in AD and
LLD, there are also important regional differences between the two
diseases.
GM volume changes in frontal–subcortical or limbic networks
are hypothesized to play an important role in the neuropathology
of LLD (Sexton et al., 2012). Indeed, several previous studies have
reported a reduction in the volume of the anterior cingulate cortex
and frontal orbital cortex in LLD (Caetano et al., 2006; Taylor et al.,
2007). Furthermore, a previous study of LLD patients using VSRAD
identiﬁed atrophy of the subgenual anterior cingulate cortex
speciﬁcally (Niida et al., 2012). This study reported that assessing
for the presence of subgenual anterior cingulate cortex atrophy is
also effective in the diagnosis of major depression with a sensi-
tivity of 90.7%. In the present VBM study, using SPM8 plus DARTEL,
we found GM atrophy in regions that were consistent with
ﬁndings from previous VBM studies of LLD. Recent functional
MRI studies have reported an association between the default-
mode network (DMN) and LLD (Wu et al., 2011; Alexopoulos et al.,
2012). In these studies, LLD patients exhibited decreased connec-
tivity in the anterior regions of the DMN (the rostral anterior
cingulate cortex, medial prefrontal and orbito-prefrontal cortex),
and increased connectivity in the posterior regions of the DMN.
Conversely, some studies have reported an association between
the DMN and AD involving a decrease in regional coherence in the
PCC and precuneus (He et al., 2007; Liu et al., 2008). While a direct
association between structural changes and functional changes in
DMN inactivation has not been established, it is possible that the
differences in the morphological changes in AD and LLD found in
our study are related to these observations.
The most interesting aspect of the present study is the assess-
ment of regional GM volume as a co-variable with MTL structural
atrophy identiﬁed in the VSRAD analysis. Our ﬁndings identiﬁed a
signiﬁcant decrease in volume in the right middle and inferior
temporal gyrus, uncus, PCC and precuneus only in the AD group. In
previous studies, the PCC and the precuneus have been identiﬁed
as the major sites of functional change in patients with AD
(Minoshima et al., 1997; Nestor et al., 2003; Berti et al., 2010),
whereas structural neuroimaging studies noted a reduction in only
the volume of MTL structures in early AD (Jack et al., 1999; Killiany
et al., 2002). Thus, there was a discrepancy between the structural
changes and functional changes observed in AD. However, more
recent VBM studies have reported the presence of precuneus, PCC,
and hippocampal atrophy in early stage AD (Shiino et al., 2006;
Karas et al., 2007). A meta-analysis of recent structural neuroima-
ging studies identiﬁed PCC, precuneus and mid-temporal lobe GM
atrophy as an antecedent biomarker that is predictive of the
progression of amnestic mild cognitive impairment (aMCI) into
AD (Whitwell et al., 2008; Gili et al., 2011). Convit et al. (2000)
reported that atrophy of the medial occipitotemporal, inferior, and
middle temporal gyrus in non-demented elderly subjects pre-
dicted an eventual cognitive decline in AD. Also, a recent func-
tional MRI study suggested that changes in the posterior areas of
the DMN as well as in the medial temporal lobes seem to be
central to AD (Sorg et al., 2009). AD cases in our study were not in
the early stages of the disease. A recent VBM study examined the
structural changes associated with increasing CDR scores in AD
patients. In this study, a signiﬁcant decrease in the volume of
MTL structures was associated with a worsening of cognitive
impairments, but this was not the case for the PCC or the
precuneus (Kim et al., 2011). Consistent with this, our ﬁndings
indicate the presence of precuneus, PCC, and middle and inferior
temporal gyrus atrophy in AD, but not in LLD. Thus, the neuro-
pathological changes that are observed in both AD and MCI
differed from those found in late-onset LLD patients with hippo-
campal atrophy. This suggests that the hippocampal atrophy
observed in late-onset LLD may reﬂect the presence of changes
that differ from the hippocampal atrophy that occurs in the
prodromal stage of AD. Furthermore, the neurodegeneration in
the subregions of the anterior DMN, in particular the ACC, could be
important in late-onset LLD patients, although some degeneration
in this region is also observed in moderate to severe AD patients.
The regions central to the cognitive deﬁcit may differ between the
AD and LLD groups. The cause of atrophy of the anterior cingulate
cortex and how this is associated with hippocampal atrophy is
complex in the LLD group. Indeed, Andreescu et al. (2008) suggest
several factors that may contribute to the heterogeneity of volu-
metric brain changes in LLD, including age of onset, time since
onset, degree of apathy, genetics, and antidepressant medication
response. It is also necessary to address additional potentially
confounding factors, such as genetics (e.g., isoforms of apolipo-
protein E (ApoE)), the presence or absence of vascular disease, the
duration of illness, and medication status. Thus, considering these
factors, we believe that a longitudinal study is required to assess
whether a LLD diagnosis is a risk factor for AD.
The current study had several limitations. This study only
assessed cases that had a degree of hippocampal atrophy detect-
able by VSRAD. Therefore, the sample size used in the study was
small. As a result the study had low statistical power, which
reduced the chance of detecting a true effect. Second, for the AD
group, we included cases of moderate as well as mild cases of
cognitive impairment. Thus, patients in the AD group could have
MMSE scores that were signiﬁcantly lower than patients in the
late-onset LLD group. Patients with LLD and aMCI and participants
with aMCI alone were not included in the study. Notably, a meta-
analysis of VBM studies examining MCI and AD identiﬁed similar
distributions of neuroanatomical changes in AD and MCI (Yang
et al., 2012). Xie et al. (2012) hypothesized that LLD with aMCI, but
not LLD alone, would be associated with widespread GM volume
loss in regions commonly implicated in mild AD. Future studies
should include comparison of cases with and without aMCI.
A longitudinal observational study of the present LLD cases is also
necessary. Furthermore, examination of psychological test bat-
teries, such as those for executive function, will be needed to
determine what kind of cognitive difﬁculties are associated with
the structural abnormalities, common to both the AD and LLD
groups, observed in the frontal part of the DMN containing
the ACC.
5. Conclusion
Our study revealed structural changes in the anterior DMN in
both the AD and LLD groups, whereas structural changes in the
posterior DMN were only observed in the AD group.
These ﬁndings were consistent with our results obtained using
atlas-based VBM. Signiﬁcantly decreased GM volume in the pre-
cuneus and PCC regions was seen in the AD group relative to the
LLD group. The late-onset LLD group exhibited morphological
changes different from those observed in AD, supporting the
results from previous VBM studies. Importantly, because LLD is a
collection of heterogeneous disorders, atrophy of the hippocampus
does not necessarily suggest an association with AD. Therefore, our
cross-sectional study provided evidence that the morphological
changes observed in AD, which are similar to those observed in
MCI, are different from those observed in LLD alone.
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